BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32224121)

  • 1. Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned.
    Choi R; Hulverson MA; Huang W; Vidadala RSR; Whitman GR; Barrett LK; Schaefer DA; Betzer DP; Riggs MW; Doggett JS; Hemphill A; Ortega-Mora LM; McCloskey MC; Arnold SLM; Hackman RC; Marsh KC; Lynch JJ; Freiberg GM; Leroy BE; Kempf DJ; Choy RKM; de Hostos EL; Maly DJ; Fan E; Ojo KK; Van Voorhis WC
    Int J Parasitol; 2020 May; 50(5):413-422. PubMed ID: 32224121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.
    Van Voorhis WC; Hulverson MA; Choi R; Huang W; Arnold SLM; Schaefer DA; Betzer DP; Vidadala RSR; Lee S; Whitman GR; Barrett LK; Maly DJ; Riggs MW; Fan E; Kennedy TJ; Tzipori S; Doggett JS; Winzer P; Anghel N; Imhof D; Müller J; Hemphill A; Ferre I; Sanchez-Sanchez R; Ortega-Mora LM; Ojo KK
    Vet Parasitol; 2021 Jan; 289():109336. PubMed ID: 33418437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.
    Ojo KK; Dangoudoubiyam S; Verma SK; Scheele S; DeRocher AE; Yeargan M; Choi R; Smith TR; Rivas KL; Hulverson MA; Barrett LK; Fan E; Maly DJ; Parsons M; Dubey JP; Howe DK; Van Voorhis WC
    Int J Parasitol; 2016 Dec; 46(13-14):871-880. PubMed ID: 27729271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection.
    Doggett JS; Ojo KK; Fan E; Maly DJ; Van Voorhis WC
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3547-9. PubMed ID: 24687502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.
    Van Voorhis WC; Doggett JS; Parsons M; Hulverson MA; Choi R; Arnold SLM; Riggs MW; Hemphill A; Howe DK; Mealey RH; Lau AOT; Merritt EA; Maly DJ; Fan E; Ojo KK
    Exp Parasitol; 2017 Sep; 180():71-83. PubMed ID: 28065755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
    Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma.
    Chellan P; Sadler PJ; Land KM
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1491-1501. PubMed ID: 28242275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of Apicomplexan protein kinases at each life cycle stage.
    Kato K; Sugi T; Iwanaga T
    Parasitol Int; 2012 Jun; 61(2):224-34. PubMed ID: 22209882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice.
    Anghel N; Winzer PA; Imhof D; Müller J; Langa X; Rieder J; Barrett LK; Vidadala RSR; Huang W; Choi R; Hulverson MA; Whitman GR; Arnold SL; Van Voorhis WC; Ojo KK; Maly DJ; Fan E; Hemphill A
    Int J Antimicrob Agents; 2020 Sep; 56(3):106099. PubMed ID: 32707170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites.
    Keyloun KR; Reid MC; Choi R; Song Y; Fox AMW; Hillesland HK; Zhang Z; Vidadala R; Merritt EA; Lau AOT; Maly DJ; Fan E; Barrett LK; Van Voorhis WC; Ojo KK
    Parasitology; 2014 Sep; 141(11):1499-1509. PubMed ID: 24927073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.
    Ojo KK; Larson ET; Keyloun KR; Castaneda LJ; Derocher AE; Inampudi KK; Kim JE; Arakaki TL; Murphy RC; Zhang L; Napuli AJ; Maly DJ; Verlinde CL; Buckner FS; Parsons M; Hol WG; Merritt EA; Van Voorhis WC
    Nat Struct Mol Biol; 2010 May; 17(5):602-7. PubMed ID: 20436472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
    Schaefer DA; Betzer DP; Smith KD; Millman ZG; Michalski HC; Menchaca SE; Zambriski JA; Ojo KK; Hulverson MA; Arnold SL; Rivas KL; Vidadala RS; Huang W; Barrett LK; Maly DJ; Fan E; Van Voorhis WC; Riggs MW
    J Infect Dis; 2016 Dec; 214(12):1856-1864. PubMed ID: 27923949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apicoplast as a potential therapeutic target in and other apicomplexan parasites.
    Soldati D
    Parasitol Today; 1999 Jan; 15(1):5-7. PubMed ID: 10234168
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts.
    Imhof D; Anghel N; Winzer P; Balmer V; Ramseier J; Hänggeli K; Choi R; Hulverson MA; Whitman GR; Arnold SLM; Ojo KK; Van Voorhis WC; Doggett JS; Ortega-Mora LM; Hemphill A
    Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():90-101. PubMed ID: 34030110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
    Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
    J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis.
    Hulverson MA; Choi R; Arnold SLM; Schaefer DA; Hemphill A; McCloskey MC; Betzer DP; Müller J; Vidadala RSR; Whitman GR; Rivas KL; Barrett LK; Hackman RC; Love MS; McNamara CW; Shaughnessy TK; Kondratiuk A; Kurnick M; Banfor PN; Lynch JJ; Freiberg GM; Kempf DJ; Maly DJ; Riggs MW; Ojo KK; Van Voorhis WC
    Int J Parasitol; 2017 Oct; 47(12):753-763. PubMed ID: 28899690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.
    Müller J; Aguado-Martínez A; Balmer V; Maly DJ; Fan E; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
    Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
    J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
    ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies.
    Coppens I
    Nat Rev Microbiol; 2013 Dec; 11(12):823-35. PubMed ID: 24162026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.